Headline News about AbbVie![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
Where AbbVie Stands With Analysts
November 18, 2022
Via Benzinga
![]()
Analyst Ratings for AbbVie
November 18, 2022
Via Benzinga
![]()
What 8 Analyst Ratings Have To Say About AbbVie
November 18, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
![]() ![]()
AbbVie's Migraine Treatment Scores Canadian Approval
November 16, 2022
Via Benzinga
![]()
Exicure Flags Bankruptcy Concerns, Shares Fall
November 15, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch
November 07, 2022
Via Benzinga
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|